Security key
03237H101
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)
CUSIP: 03237H101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 110,465,093
- Total 13F shares
- 54,545,075
- Share change
- +3,184,647
- Total reported value
- $1,176,653,052
- Put/Call ratio
- 32%
- Price per share
- $21.57
- Number of holders
- 153
- Value change
- +$56,163,167
- Number of buys
- 95
- Number of sells
- 63
Report period
Q2 2023
Institutions
153
Top holders
10
AMLX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Amylyx Pharmaceuticals, Inc. SEC filings
Amylyx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03237H101
Recent filing periods:
Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.5%
|
6,034,644
|
$177,056,455 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
4,747,341
|
$139,286,986 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
3,614,918
|
$106,061,695 | — | 31 Mar 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
3/4/5
|
Company · 10%+ Owner |
2.7%
|
2,962,555
|
$86,921,364 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.9%
|
2,084,000
|
$61,145,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.8%
|
2,022,370
|
$59,336,336 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
1,984,333
|
$58,220,330 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.7%
|
1,846,117
|
$54,165,073 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
1,452,816
|
$42,625,621 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.3%
|
1,433,846
|
$42,069,042 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,366,172
|
$40,083,487 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1%
|
1,139,240
|
$33,425,302 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.97%
|
1,074,610
|
$31,529,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.97%
|
1,066,238
|
$31,283,423 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.91%
|
1,007,336
|
$29,555,238 | — | 31 Mar 2023 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.88%
|
972,835
|
$28,542,979 | — | 31 Mar 2023 | |
| Alpha Wave Global, LP |
13F
|
Company |
0.84%
|
930,337
|
$27,296,088 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
902,547
|
$26,480,729 | — | 31 Mar 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.81%
|
900,000
|
$26,406,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
890,982
|
$26,141,422 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.74%
|
813,500
|
$23,868,090 | — | 31 Mar 2023 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.71%
|
789,591
|
$23,166,600 | — | 31 Mar 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.71%
|
783,795
|
$22,996,545 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.56%
|
619,030
|
$18,162,340 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.55%
|
611,932
|
$17,954,000 | — | 31 Mar 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.43%
|
475,000
|
$13,937,000 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.43%
|
473,100
|
$13,880,754 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
463,880
|
$13,610,240 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
458,054
|
$13,439,304 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.39%
|
434,200
|
$12,739,428 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.38%
|
420,841
|
$12,347,475 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.36%
|
393,904
|
$11,557,000 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.29%
|
324,800
|
$9,529,632 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
320,086
|
$9,391,323 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.26%
|
285,005
|
$8,362,046 | — | 31 Mar 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.25%
|
277,788
|
$8,150,299 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.24%
|
264,858
|
$7,770,934 | — | 31 Mar 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.23%
|
251,407
|
$7,376,281 | — | 31 Mar 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.23%
|
250,042
|
$7,336,000 | — | 31 Mar 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
242,400
|
$7,112,016 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.21%
|
228,906
|
$6,716,102 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.2%
|
221,598
|
$6,501,685 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
212,453
|
$6,233,371 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
204,656
|
$6,004,607 | — | 31 Mar 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.17%
|
185,000
|
$5,427,900 | — | 31 Mar 2023 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.16%
|
177,200
|
$5,199,048 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
135,465
|
$3,974,543 | — | 31 Mar 2023 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.12%
|
131,772
|
$3,866,190 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.1%
|
108,429
|
$3,181,307 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
101,700
|
$2,984,000 | — | 31 Mar 2023 |
Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q2 2023
As of 30 Jun 2023,
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,545,075 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VIKING GLOBAL INVESTORS LP, Boxer Capital, LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., Rock Springs Capital Management LP, and FEDERATED HERMES, INC..
This page lists
153
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
145
Q2 2023 holders
153
Holder diff
8
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.